Cargando…
Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019
Although the administration of the Bacillus Calmette–Guérin (BCG) vaccine is generally safe, lymphadenitis, the most common complication of BCG vaccination, can occur. Here, we describe the epidemiological characteristics and incidence trends of BCG lymphadenitis in Shanghai, China, among a populati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920159/ https://www.ncbi.nlm.nih.gov/pubmed/34156902 http://dx.doi.org/10.1080/21645515.2021.1938922 |
_version_ | 1784669066892410880 |
---|---|
author | Wang, Jing Zhou, Feng Jiang, Ming-Bo Xu, Zhen-hui Ni, Yi-hong Wu, Qiang-Song |
author_facet | Wang, Jing Zhou, Feng Jiang, Ming-Bo Xu, Zhen-hui Ni, Yi-hong Wu, Qiang-Song |
author_sort | Wang, Jing |
collection | PubMed |
description | Although the administration of the Bacillus Calmette–Guérin (BCG) vaccine is generally safe, lymphadenitis, the most common complication of BCG vaccination, can occur. Here, we describe the epidemiological characteristics and incidence trends of BCG lymphadenitis in Shanghai, China, among a population with a high burden of tuberculosis. A total of 56 cases of adverse events following immunization (AEFI) after BCG vaccination were reported in Shanghai, including 51 cases of BCG lymphadenitis (91.07%), from 2010 to 2019. The general incidence of BCG lymphadenitis was 173 per 1,000,000 doses in Shanghai from 2010 to 2019. A nonsignificant increase of 58.81% per year was observed between 2010 and 2012 (t = 0.93; p = .40), followed by a significant decline of 28.00% per year from 2012 to 2019 (t = −4.27; p < .01). Seven batches of BCG vaccines triggered three or more BCG lymphadenitis cases, for 27 (52.94%) cases in total. We identified two patients with immunodeficiency of chronic granulomatous disease, one of whom died four years later after BCG vaccination and another of whom was still being treated after two transplants. The average total care cost of the 47 recovered cases was 11,336 RMB (range: 2,637–33,861 RMB). Due to the high burden of BCG lymphadenitis, especially in children with immunodeficiency, it is suggested that government departments should strengthen healthcare provider training, assign specific nurses to perform BCG vaccination, monitor vaccinated individuals actively and timely detect abnormal signals so as to reduce the incidence of BCG lymphadenitis. |
format | Online Article Text |
id | pubmed-8920159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89201592022-03-15 Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 Wang, Jing Zhou, Feng Jiang, Ming-Bo Xu, Zhen-hui Ni, Yi-hong Wu, Qiang-Song Hum Vaccin Immunother Licensed Vaccines – Research Paper Although the administration of the Bacillus Calmette–Guérin (BCG) vaccine is generally safe, lymphadenitis, the most common complication of BCG vaccination, can occur. Here, we describe the epidemiological characteristics and incidence trends of BCG lymphadenitis in Shanghai, China, among a population with a high burden of tuberculosis. A total of 56 cases of adverse events following immunization (AEFI) after BCG vaccination were reported in Shanghai, including 51 cases of BCG lymphadenitis (91.07%), from 2010 to 2019. The general incidence of BCG lymphadenitis was 173 per 1,000,000 doses in Shanghai from 2010 to 2019. A nonsignificant increase of 58.81% per year was observed between 2010 and 2012 (t = 0.93; p = .40), followed by a significant decline of 28.00% per year from 2012 to 2019 (t = −4.27; p < .01). Seven batches of BCG vaccines triggered three or more BCG lymphadenitis cases, for 27 (52.94%) cases in total. We identified two patients with immunodeficiency of chronic granulomatous disease, one of whom died four years later after BCG vaccination and another of whom was still being treated after two transplants. The average total care cost of the 47 recovered cases was 11,336 RMB (range: 2,637–33,861 RMB). Due to the high burden of BCG lymphadenitis, especially in children with immunodeficiency, it is suggested that government departments should strengthen healthcare provider training, assign specific nurses to perform BCG vaccination, monitor vaccinated individuals actively and timely detect abnormal signals so as to reduce the incidence of BCG lymphadenitis. Taylor & Francis 2021-06-22 /pmc/articles/PMC8920159/ /pubmed/34156902 http://dx.doi.org/10.1080/21645515.2021.1938922 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Licensed Vaccines – Research Paper Wang, Jing Zhou, Feng Jiang, Ming-Bo Xu, Zhen-hui Ni, Yi-hong Wu, Qiang-Song Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title | Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title_full | Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title_fullStr | Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title_full_unstemmed | Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title_short | Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019 |
title_sort | epidemiological characteristics and trends of bacillus calmette–guérin lymphadenitis in shanghai, china from 2010 to 2019 |
topic | Licensed Vaccines – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920159/ https://www.ncbi.nlm.nih.gov/pubmed/34156902 http://dx.doi.org/10.1080/21645515.2021.1938922 |
work_keys_str_mv | AT wangjing epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 AT zhoufeng epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 AT jiangmingbo epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 AT xuzhenhui epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 AT niyihong epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 AT wuqiangsong epidemiologicalcharacteristicsandtrendsofbacilluscalmetteguerinlymphadenitisinshanghaichinafrom2010to2019 |